Tumor Budding and T1 Substaging in Urothelial Bladder Cancer
Assiut University
Assiut University
Umeå University
Assiut University
Sohag University
Poitiers University Hospital
Rutgers, The State University of New Jersey
Protara Therapeutics
University of Iowa
Institut Cancerologie de l'Ouest
University of Washington
Relmada Therapeutics, Inc.
Istituto Clinico Humanitas
Memorial Sloan Kettering Cancer Center
VA Office of Research and Development
Brazilian Clinical Research Institute
Second Life Therapeutics
Institut du Cancer de Montpellier - Val d'Aurelle
Institut Cancerologie de l'Ouest
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
IRCCS San Raffaele
AC.TA. S.r.l.
Rutgers, The State University of New Jersey
Bitlis Eren University
Western University, Canada
Assiut University
First Affiliated Hospital of Wenzhou Medical University
Assiut University
Sir Mortimer B. Davis - Jewish General Hospital
National Cancer Center, Korea
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Chinese University of Hong Kong
Qilu Hospital of Shandong University
Peking University First Hospital
Peking University First Hospital
Duke University
National Taiwan University Hospital
Sun Yat-sen University
Ankara University
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Xijing Hospital
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Ziekenhuis Oost-Limburg
IRCCS San Raffaele
A.O.U. Città della Salute e della Scienza
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
European Organisation for Research and Treatment of Cancer - EORTC
Changhai Hospital
Changhai Hospital
Dokuz Eylul University
Fondazione IRCCS Policlinico San Matteo di Pavia